Cell line name |
ISH/DDP |
Accession |
CVCL_IR24 |
Resource Identification Initiative |
To cite this cell line use: ISH/DDP (RRID:CVCL_IR24) |
Comments |
Population: Japanese. Doubling time: 40.1 hours (PubMed=22041447). Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP). Derived from site: In situ; Endometrium; UBERON=UBERON_0001295. |
Sequence variations |
- Mutation; HGNC; 8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
|
Disease |
Endometrial adenocarcinoma (NCIt: C7359) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_2529 (Ishikawa) |
Sex of cell |
Female |
Age at sampling |
39Y |
Category |
Cancer cell line |
Publications | PubMed=22041447; DOI=10.3760/cma.j.issn.0529-567x.2011.07.012 Xu Q.-Y., Chen Y.-H., Zhao L.-J., Li X.-P., Wang J.-L., Wei L.-H. Establishment of cisplatin-resistant human endometrial cancer cell line and the study of its resistant mechanisms. Zhonghua Fu Chan Ke Za Zhi 46:533-537(2011) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_IR24
|
Encyclopedic resources |
Wikidata; Q54898277
|
Entry history |
Entry creation | 03-Mar-2017 |
Last entry update | 05-Oct-2023 |
Version number | 9 |
---|